Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0-N1 nonsmall cell lung cancer and malignant pleural effusion?

Conclusion Although reported survival in this systematic review is encouraging, available evidence concerning debulking surgery and HITHOC in N0–N1 NSCLC with malignant pleural effusion is weak. Better evidence in the form of a randomised controlled trial is mandatory.

http://err.ersjournals.com/cgi/content/short/28/153/190018?rss=1

Source: European Respiratory Review - July 30, 2019 Category: Respiratory Medicine Authors: Migliore, M., Nardini, M. Tags: Lung cancer Systematic review Source Type: research